Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
fda
archive
medical
clinical trials
life sciences
national blog main
abbvie
allergan
andrew berens
avapritinib
big pharma
biotech
blueprint medicines
boehringer ingelheim
boston
boston blog main
cancer
coronavirus
deciphera pharmaceuticals
eli lilly
empagliflozin
europe
europe blog main
europe top stories
extreme
eye drops
gastrointestinal stromal tumor
gist
gleevec
imatinib
indiana blog main
indiana top stories
medicine
new york blog main
new york top stories
pharmaceuticals
recall
recalls
regorafenib
ripretinib
What
fda
7
×
type
7
×
drug
approves
cancer
approval
diabetes
impurity
new
recalled
risk
short
treats
used
acute
announced
batch
battelle
benefit
bid
blood
blueprint
boehringer
called
cause
caused
causing
chasing
commonly
contracting
coronavirus
countries
critically
days
deadly
deciphera
decontaminating
development
diabetics
disrupting
Language
unset
7
×
Current search:
type
×
unset
×
fda
×
@extremetech.com
2 years ago
FDA Approves New Eye Drops that Could Replace Glasses for Millions
@slashgear.com
3 years ago
Popular diabetes drug recalled months after FDA issued cancer risk warning
@slashgear.com
4 years ago
Another batch of metformin recalled over cancer-causing impurity
@slashgear.com
4 years ago
FDA approves Battelle tech for decontaminating N95 respirators
@xconomy.com
4 years ago
FDA Rejects Boehringer Ingelheim, Eli Lilly Drug for Type 1 Diabetes
@slashgear.com
4 years ago
FDA approves new drug that immediately treats migraines
@xconomy.com
4 years ago
Chasing Blueprint, Deciphera Plans FDA Filing for GI Cancer Drug